The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-fluoro-4-(2-(isoxazol-3-yl)hydrazinyl)-N-phenethylquinazolin-2-amine ID: ALA4860235
PubChem CID: 164618085
Max Phase: Preclinical
Molecular Formula: C19H16FN5O
Molecular Weight: 349.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Fc1cccc2nc(NCCc3ccccc3)nc(Nc3ccon3)c12
Standard InChI: InChI=1S/C19H16FN5O/c20-14-7-4-8-15-17(14)18(23-16-10-12-26-25-16)24-19(22-15)21-11-9-13-5-2-1-3-6-13/h1-8,10,12H,9,11H2,(H2,21,22,23,24,25)
Standard InChI Key: MSSPUQWXXCTHAQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
9.2873 -13.1960 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.6586 -15.2928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9929 -14.4344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7070 -14.0239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9500 -14.0646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5637 -15.2509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6616 -14.4779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4139 -14.4434 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2420 -15.2896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2814 -14.0168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2399 -14.4752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9861 -15.2572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6936 -15.6687 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7127 -13.2030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8260 -15.2795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2718 -15.6607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5667 -14.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9497 -15.7010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1119 -15.6815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5326 -15.6943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4052 -15.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4232 -12.7993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1646 -13.1346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7156 -12.5311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3118 -11.8205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5114 -11.9850 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7 5 1 0
16 12 1 0
21 8 2 0
2 7 2 0
18 2 1 0
15 20 1 0
5 11 2 0
8 4 1 0
17 6 1 0
10 17 2 0
4 3 2 0
10 1 1 0
11 9 1 0
12 3 1 0
21 19 1 0
4 14 1 0
9 18 2 0
9 20 1 0
19 15 1 0
12 13 2 0
3 10 1 0
6 16 2 0
13 21 1 0
14 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 1 0
26 22 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 349.37Molecular Weight (Monoisotopic): 349.1339AlogP: 4.16#Rotatable Bonds: 6Polar Surface Area: 75.87Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.70CX Basic pKa: 5.20CX LogP: 4.73CX LogD: 4.70Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: -1.60
References 1. Uehling DE, Joseph B, Chung KC, Zhang AX, Ler S, Prakesch MA, Poda G, Grouleff J, Aman A, Kiyota T, Leung-Hagesteijn C, Konda JD, Marcellus R, Griffin C, Subramaniam R, Abibi A, Strathdee CA, Isaac MB, Al-Awar R, Tiedemann RE.. (2021) Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma., 64 (15.0): [PMID:34291633 ] [10.1021/acs.jmedchem.1c00506 ] 2. Tesmer, John J G JJ, Tesmer, Valerie M VM, Lodowski, David T DT, Steinhagen, Henning H and Huber, Jochen J. 2010-02-25 Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol. [PMID:20128603 ]